(Q44468910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Peter J. Snyder

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

R H Pietrzak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Nutrition, Health and Aging

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

268-273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

22 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12603-009-0071-4

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12603-009-0071-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0071-4

Variability in cognitive presentation of Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Effects of donepezil on verbal memory after semantic processing in healthy older adults

1 reference

12 December 2020

Neuropsychological test performance in healthy volunteers before and after donepezil administration

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

12 December 2020

Reaction times and performance variability in normal aging, mild cognitive impairment, and Alzheimer's disease

1 reference

12 December 2020

Cholinergic enhancement of episodic memory in healthy young adults.

1 reference

12 December 2020

The influence of different error estimates in the detection of post-operative cognitive dysfunction using reliable change indices with correction for practice effects

1 reference

12 December 2020

Cholinesterase inhibitors for Alzheimer's disease

1 reference

12 December 2020

Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals.

1 reference

12 December 2020

The role of acetylcholine in learning and memory

1 reference

12 December 2020

An examination of the construct validity and factor structure of the Groton Maze Learning Test, a new measure of spatial working memory, learning efficiency, and error monitoring.

1 reference

12 December 2020

A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam

1 reference

12 December 2020

Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study.

1 reference

12 December 2020

Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study

1 reference

12 December 2020

Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor.

1 reference

12 December 2020

A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.

1 reference

12 December 2020

Donepezil and flight simulator performance: effects on retention of complex skills

1 reference

12 December 2020

Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study

1 reference

12 December 2020

Convergent validity and effect of instruction modification on the groton maze learning test: a new measure of spatial working memory and error monitoring

1 reference

12 December 2020

The sensitivity and specificity of three common statistical rules for the classification of post-operative cognitive dysfunction following coronary artery bypass graft surgery.

1 reference

12 December 2020

Spatial learning efficiency and error monitoring in normal aging: an investigation using a novel hidden maze learning test.

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

1 reference

12 December 2020

Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex

1 reference

12 December 2020

The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine

1 reference

12 December 2020

A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam.

1 reference

12 December 2020

Development of a statistical approach to classifying treatment response in individual children with ADHD.

1 reference

12 December 2020

10.1007/S12603-009-0071-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19262966%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference